Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strains.
Inbred rat strains BDIX and BDIV are constitutionally susceptible and resistant, respectively, to the development of malignant peripheral nerve sheath tumors (MPNST) induced by neonatal exposure to N-ethyl-N-nitrosourea (EtNU). They represent a model system for analysis of molecular and cellular processes underlying differential cancer susceptibility. A point mutation in the Neu/ErbB-2 gene is an early marker of Schwann precursor cells at high risk of malignant conversion and is diagnostic of the resulting MPNST predominantly developing in the trigeminal nerves. Initially considerable amounts of Neu/ErbB-2-mutant cells arise in nerve tissue of both rat strains subsequently disappearing in resistant BDIV rats, but persisting and giving rise to MPNST in susceptible BDIX animals. An almost identical cellular immune response-sequentially involving macrophages, T helper- and cytotoxic T lymphocytes-is mounted in the trigeminal nerves of EtNU-treated rats of both strains. In this study, T cell maturation was prevented by neonatal thymectomy following EtNU-exposure. While resistance against MPNST development significantly decreased in BDIV rats MPNST incidence and survival time remained unaltered in thymectomized BDIX rats. Contrary to euthymic animals a number of both thymectomized BDIV and BDIX rats developed MPNST lacking the Neu/ErbB-2-mutation. This suggests that Schwann cells initiated by other genetic alterations can progress to full malignancy in immune-compromised rats only. T cell-dependent resistance against tumorigenesis originating from non-Neu/ErbB-2-mutant Schwann precursors might thus be shared by both strains while BDIV T lymphocytes additionally prevent the development of Neu/ErbB-2-mutant MPNST. Rat strain-specific differences in the interaction of T lymphocytes with (pre)malignant Neu-mutant cells may thus critically contribute to susceptibility and resistance towards EtNU-induced MPNST development.
Marx
Judith A M
JA
Department of Neuropathology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, Bonn, Germany.
Röhrborn
Ansgar J
AJ
Koelsch
Bernd U
BU
Fischer
Christine
C
Herrmann
Thomas
T
Pietsch
Torsten
T
Rajewsky
Manfred F
MF
Kindler-Röhrborn
Andrea
A
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D003390:Cranial Nerve Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D005038:Ethylnitrosourea / Q000633:toxicity; D018734:Genes, erbB-2 / Q000235:genetics*; D053208:Kaplan-Meier Estimate; D008212:Lymphocyte Depletion; D017354:Point Mutation; D051381:Rats; D011919:Rats, Inbred Strains; D012583:Schwann Cells / Q000187:drug effects / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014276:Trigeminal Nerve / Q000276:immunology / Q000473:pathology; D020433:Trigeminal Nerve Diseases / Q000139:chemically induced / Q000235:genetics / Q000276:immunology* / Q000473:pathology
D000477:Alkylating Agents; D005038:Ethylnitrosourea